• Arteris, Inc. has reported its first quarter 2026 results, with revenue rising to US$22.94 million from US$16.53 million a year earlier, while net loss narrowed slightly to US$7.96 million, and the company updated guidance and announced the upcoming retirement of Chief Financial Officer Nicholas B. Hawkins.
• Alongside the strong revenue growth, Arteris highlighted record contract metrics, including higher annual contract value and remaining performance obligations, underscoring a growing base of contracted future revenue despite ongoing integration costs from its Cycuity acquisition.
• We will now examine how Arteris' strong revenue growth and expanding contracted backlog could influence its existing investment narrative and assumptions.

Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Arteris Investment Narrative Recap

To own Arteris, you need to be comfortable backing a high‑growth, loss‑making IP business that is trying to turn strong design‑win momentum into durable, cash‑generating contracts. The latest quarter’s revenue lift and record contract metrics support this thesis, but the key near‑term catalyst remains execution on that expanding backlog, while the biggest risk is still that operating costs and acquisition integration keep profitability out of reach for longer. The new guidance does not appear to materially change that balance.

The most relevant recent development here is Arteris’ Q1 2026 report, which paired 39% year‑over‑year revenue growth to US$22.94 million with higher Annual Contract Value and Remaining Performance Obligations. This pairing of headline growth and deeper contracted backlog sits at the heart of the bull case that AI, automotive, and chiplet demand can sustain rising top‑line while margins gradually improve, even as the Cycuity acquisition and an upcoming CFO transition add some execution risk.

Yet beneath the strong contract growth, investors should be aware of how persistent losses and rising operating expenses could still...

Arteris' narrative projects $130.9 million revenue and $15.0 million earnings by 2029. This requires 22.9% yearly revenue growth and a $49.7 million earnings increase from -$34.7 million today.

Uncover how Arteris' forecasts yield a $20.50 fair value, a 37% downside to its current price.

Exploring Other Perspectives

Some of the lowest‑priced analysts were already cautious, assuming revenue of about US$137.1 million by 2029 and ongoing losses, so this stronger quarter may eventually challenge their concern that high R&D and operating costs will keep margins under pressure.

Explore 5 other fair value estimates on Arteris - why the stock might be worth less than half the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Arteris research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Arteris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arteris' overall financial health at a glance.

Seeking Other Investments?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Rare earth metals are the new gold rush. Find out which 33 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.